Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 32 results.
User Information
Export Records
  1. 1.   Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance
  2. Zhu, Bin; Xiao, Yanzi; Yeager,Meredith; Clifford, Gary; Wentzensen, Nicolas; Cullen,Michael; Boland,Joseph; Bass,Sara; Steinberg,Mia; Raine-Bennett, Tina; Lee, DongHyuk; Burk, Robert D; Pinheiro, Maisa; Song,Lei; Dean, Michael; Nelson, Chase W; Burdett,Laurie; Yu, Kai; Roberson, David; Lorey, Thomas; Franceschi, Silvia; Castle, Philip E; Walker, Joan; Zuna, Rosemary; Schiffman, Mark; Mirabello, Lisa
  3. Nature communications. 2020, Feb 14; 11(1): pii: 10.1038/s41467-020-14730-1.
  1. 2.   An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) Study
  2. Beachler, Daniel C.; Pinto, Ligia; Kemp, Troy; Nyitray, Alan G.; Hildesheim, Allan; Viscidi, Raphael; Schussler, John; Kreimer, Aimee R.; Giuliano, Anna R.
  3. Cancer Epidemiology Biomarkers & Prevention. 2018, Apr; 27(4): 496-502.
  1. 3.   Data Descriptor: Matched computed tomography segmentation and demographic data for oropharyngeal cancer radiomics challenges
  2. Elhalawani, Hesham; Mohamed, Abdallah S. R.; White, Aubrey L.; Zafereo, James; Wong, Andrew J.; Berends, Joel E.; AboHashem, Shady; Williams, Bowman; Aymard, Jeremy M.; Kanwar, Aasheesh; Perni, Subha; Rock, Crosby D.; Cooksey, Luke; Campbell, Shauna; Ding, Yao; Lai, Stephen Y.; Marai, Elisabeta G.; Vock, David; Canahuate, Guadalupe M.; Freymann, John; Farahani, Keyvan; Kalpathy-Cramer, Jayashree; Fuller, Clifton D.
  3. SCIENTIFIC DATA. 2017, Jul 04; 4
  1. 4.   TLR-based immune adjuvants
  2. Steinhagen, F.; Kinjo, T.; Bode, C.; Klinman, D. M.
  3. Vaccine. 2011, Apr; 29(17): 3341-3355.
  1. 5.   Increased plasma levels of adipokines and inflammatory markers in older women with persistent HPV infection
  2. Baker, R.; Dauner, J. G.; Rodriguez, A. C.; Williams, M. C.; Kemp, T. J.; Hildesheim, A.; Pinto, L. A.
  3. Cytokine. 2011, Mar; 53(3): 282-285.
  1. 6.   HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer
  2. Martin, M. P.; Borecki, I. B.; Zhang, Z. Y.; Nguyen, L.; Ma, D. D.; Gao, X. J.; Qi, Y.; Carrington, M.; Rader, J. S.
  3. Immunogenetics. 2010, Dec; 62(11-12): 761-765.
  1. 7.   Behavioral/Lifestyle and Immunologic Factors Associated with HPV Infection among Women Older Than 45 Years
  2. Gonzalez, P.; Hildesheim, A.; Rodriguez, A. C.; Schiffman, M.; Porras, C.; Wacholder, S.; Pineres, A. G.; Pinto, L. A.; Burk, R. D.; Herrero, R.
  3. Cancer Epidemiology Biomarkers & Prevention. 2010, Dec; 19(12): 3044-3054.
  1. 8.   Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccine
  2. Dauner, J. G.; Pan, Y. J.; Hildesheim, A.; Harro, C.; Pinto, L. A.
  3. Vaccine. 2010, Jul; 28(33): 5407-5413.
  1. 9.   Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer
  2. Wang, S. S.; Gonzalez, P.; Yu, K.; Porras, C.; Li, Q. Z.; Safaeian, M.; Rodriguez, A. C.; Sherman, M. E.; Bratti, C.; Schiffman, M.; Wacholder, S.; Burk, R. D.; Herrero, R.; Chanock, S. J.; Hildesheim, A.
  3. Plos One. 2010, Jan; 5(1): 7.
  1. 10.   Geographic Variation in the Prevalence of Kaposi Sarcoma-Associated Herpesvirus and Risk Factors for Transmission
  2. de Sanjose, S.; Mbisa, G.; Perez-Alvarez, S.; Benavente, Y.; Sukvirach, S.; Nguyen, T. H.; Shin, H. R.; Pham, T.; Thomas, J.; Lazcano, E.; Matos, E.; Herrero, R.; Munoz, N.; Molano, M.; Franceschi, S.; Whitby, D.
  3. Journal of Infectious Diseases. 2009 199(10): 1449-1456.
  1. 11.   Gene Expression Patterns Induced by HPV-16 L1 Virus-Like Particles in Leukocytes from Vaccine Recipients
  2. Garcia-Pineres, A. J.; Hildesheim, A.; Dodd, L.; Kemp, T. J.; Yang, J.; Fullmer, B.; Harro, C.; Lowy, D. R.; Lempicki, R. A.; Pinto, L. A.
  3. Journal of Immunology. 2009 182(3): 1706-1729.
  1. 12.   Determinants and Correlation of Systemic and Cervical Concentrations of Total IgA and IgG
  2. Safaeian, M.; Kemp, T.; Falk, R. T.; Rodriguez, A. C.; Hildesheim, A.; Williams, M.; Porras, C.; Herrero, R.; Pinto, L. A.
  3. Cancer Epidemiology Biomarkers & Prevention. 2009 18(10): 2672-2676.
  1. 13.   Evaluation of two types of sponges used to collect cervical secretions and assessment of antibody extraction protocols for recovery of neutralizing anti-human papillomavirus type 16 antibodies
  2. Kemp, T. J.; Hildesheim, A.; Falk, R. T.; Schiller, J. T.; Lowy, D. R.; Rodriguez, A. C.; Pinto, L. A.
  3. Clinical and Vaccine Immunology. 2008 15(1): 60-64.
  1. 14.   Educational level and cervical cancer screening programs in a Venezuelan urban area
  2. Nunez-Troconis, J.; Velasquez, J.; Mindiola, R.; Munroe, D.
  3. Investigacion Clinica. 2008 49(3): 331-339.
  1. 15.   Evaluation of the association with cervical cancer of polymorphisms in syndecan-1, a heparan sulfate proteoglycan involved with viral cell entry
  2. Yu, K. J.; Bashirova, A.; Madeleine, M. M.; Cheng, J.; Johnson, L. G.; Schwartz, S. M.; Carrington, M.; Hildesheim, A.
  3. Cancer Epidemiology Biomarkers & Prevention. 2007, Nov; 16(11): 2504-2508.
  1. 16.   Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 virus-like particles
  2. Garcia-Pineres, A.; Hildesheim, A.; Dodd, L.; Kemp, T. J.; Williams, M.; Harro, C.; Lowy, D. R.; Schiller, J. T.; Pinto, L. A.
  3. Clinical and Vaccine Immunology. 2007, Aug; 14(8): 984-989.
  1. 17.   Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan
  2. Roberts, J. N.; Buck, C. B.; Thompson, C. D.; Kines, R.; Bernardo, M.; Choyke, P. L.; Lowy, D. R.; Schiller, J. T.
  3. Nature Medicine. 2007, Jul; 13(7): 857-861.
  1. 18.   Down-regulation of insulin-like growth factor binding protein-5 (IGFBP-5): Novel marker for cervical carcinogenesis
  2. Miyatake, T.; Ueda, Y.; Nakashima, R.; Yoshino, K.; Kimura, T.; Murata, T.; Nomura, T.; Fujita, M.; Buzard, G. S.; Enomoto, T.
  3. International Journal of Cancer. 2007, May; 120(10): 2068-2077.
  1. 19.   Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis
  2. Matthews, C. P.; Birkholz, A. M.; Baker, A. R.; Perella, C. M.; Becky, G. R.; Young, M. R.; Colburn, N. H.
  3. Cancer Research. 2007, Mar; 67(6): 2430-2438.
  1. 20.   Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles
  2. Pinto, L. A.; Viscidi, R.; Harro, C. D.; Kemp, T. J.; Garcia-Pineres, A. J.; Trivett, M.; Demuth, F.; Lowy, D. R.; Schiller, J. T.; Berzofsky, J. A.; Hildesheim, A.
  3. Virology. 2006, Sep; 353(2): 451-462.
  1. 21.   Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine
  2. Garcia-Pineres, A. J.; Hildesheim, A.; Trivett, M.; Williams, M.; Wu, L.; KewalRamani, V. N.; Pinto, L. A.
  3. European Journal of Immunology. 2006, Feb; 36(2): 437-445.
  1. 22.   Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma
  2. Kovacic, M. B.; Martin, M.; Gao, X. J.; Fuksenko, T.; Chen, C. J.; Cheng, Y. J.; Chen, J. Y.; Apple, R.; Hildesheim, A.; Carrington, M.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, NOV; 14(11, Part 1): 2673-2677.
  1. 23.   Human leukocyte antigen class I and II haplotypes and risk of cervical cancer
  2. Carreon, J. D.; Martin, M. P.; Hildesheim, A.; Gao, X.; Schiffman, M.; Herrero, R.; Bratti, M. C.; Sherman, M. E.; Zaino, R. J.; Carrington, M.; Wang, S. S.
  3. Tissue Antigens. 2005, OCT; 66(4): 321-324.
  1. 24.   Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci
  2. Carrington, M.; Wang, S.; Martin, M. P.; Gao, X. J.; Schiffman, M.; Cheng, J.; Herrero, R.; Rodriguez, A. C.; Kurman, R.; Mortel, R.; Schwartz, P.; Glass, A.; Hildesheim, A.
  3. Journal of Experimental Medicine. 2005, APR 4; 201(7): 1069-1075.
  1. 25.   Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer
  2. Kanao, H.; Enomoto, T.; Ueda, Y.; Fujita, M.; Nakashima, R.; Ueno, Y.; Miyatake, T.; Yoshizaki, T.; Buzard, G. S.; Kimura, T.; Yoshino, K.; Murata, Y.
  3. Cancer Letters. 2004, SEP 15; 213(1): 31-37.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel